Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials
Maya Merabishvili, Jean-Paul Pirnay, Gilbert Verbeken et al. · 2009
Read Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials by Maya Merabishvili, Jean-Paul Pirnay, Gilbert Verbeken et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004944.txt.
Description
Burn wounds often get infected with stubborn bacteria. Two culprits are Pseudomonas aeruginosa and Staphylococcus aureus. Both often resist antibiotics. Maya Merabishvili and colleagues described a different weapon in PLOS ONE in 2009. They produced a cocktail of bacteriophages in the lab. Bacteriophages are viruses that kill bacteria. The cocktail was designed for burn patients.
Their phages were chosen to be purely lytic. That means they destroy their bacterial hosts. The small batch passed careful quality control. The paper sets out the production steps for human clinical trials. It is a practical step toward phage therapy for drug-resistant wound infections.
Catalog record
| CREATOR | Maya Merabishvili, Jean-Paul Pirnay, Gilbert Verbeken et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004944